Smith v. Nevin

73 F.2d 940, 22 C.C.P.A. 748, 1934 CCPA LEXIS 266
CourtCourt of Customs and Patent Appeals
DecidedDecember 10, 1934
DocketPatent Appeal 3353
StatusPublished
Cited by7 cases

This text of 73 F.2d 940 (Smith v. Nevin) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Smith v. Nevin, 73 F.2d 940, 22 C.C.P.A. 748, 1934 CCPA LEXIS 266 (ccpa 1934).

Opinion

GRAHAM, Presiding Judge.

The United States Patent Office declared two interferences. The first was between the application of the appellant, Arthur E. Smith, filed March 25,1927, serial No. 178389, and an application of the appellee, Mendel Nevin, filed July 3, 1926, serial No. 120417, and was numbered 58513. The subject-matter of this interference was a combination of a hypodermic syringe and ampoule to be used therewith. This interference included one count and was declared June 18, 1929.

The other interference involved was declared June 30, 1930, and involved an application of the appellee, Mendel Nevin, filed June 4, 1928, and a patent issued to the appellant on June 25, 1929, No. 1,718,594, on an application filed March 24, 1927. This interference also contained one count, and was numbered 60100. On March 17, 1931, an additional count was added to said interference No. 58513 by the Examiner, pursuant to a decision of the Board of Appeals. Thereafter the Examiner of Interferences consolidated said interferences, renumbering *941 the counts. Count 3 of said interference was eopied from the Smith patent 1,718,594. The parties to this consolidated interference had been involved in prior interferences, and a motion to dissolve on the ground of estoppel had been interposed in one of these interferences, and was renewed in the present appeal on priority, under the provisions of rule 130 of the Patent Office. In this appeal, the Board of Appeals denied the motion to dissolve.

No error is assigned by the party Smith on this action. It will therefore be considered as waived by him.

The counts of the interference are as follows:

“1. The combination of a syringe and an ampule, said ampule having a stopper movable therein, said stopper having a central recess therein, a plunger including a head and a shank mounted on said syringe, said plunger head being of a larger size than its shank and of less size than the bore of the ampule, said plunger having its end arranged to seat in said rceess and an ampule engaging member surrounding- said plunger shank and including a part movable within the syringe to engage the ampule in the barrel.

“2. The combination of a syringe and an ampule, said ampule having a stopper movable therein, said stopper having a recess therein, a plunger including a head and a shank mounted on said syringe, said plunger head being of a larger size than its shank and of less size than the bore of the ampule, said head having at least a portion of its sides tapered, said plunger having its ends arranged to seat in said recess and an ampule engaging member surrounding said plunger shank and including a part movable within the syringe to engage the ampule in the barrel.

“3. In a syringe, a barrel having a closure for one end thereof, said closure including an ampule holding member for engaging the end of an ampule, a plunger, said plunger being movable within said barrel and through said ampule holding member, a tip on said barrel, a needle on said tip, said tip having a tapered recess therein, an ampule in said barrel, said ampule including a hollow body portion and an end portion tapered to approximate the taper of said recess, a stopper in said body portion adapted to be engaged by said plunger, a resilient collar adapted to fit said tapered end portion of said body, said resilient collar being of a length greater than the thickness thereof and being adapted to fit within said tapered recess of said tip, whereby when pressure is applied to said ampule by said ampule holding member said resilient collar will be expanded in said recess without rolling and will engage the wall of said recess and the tapered end portion of the ampule to form a fluid tight seal between said ampule and said tip and releasable means to hold said ampule holding member in position.”

The Examiner of Interferences found that the party Nevin should be restricted to his filing date for conception and reduction to practice, namely, July 3, 1926. He found also that the party Smith conceived his invention prior to November, 1922, but held that this was an" abandoned experiment, and that the party Smith “slept on his rights until possibly spurred into activity by the sale to Smith’s customers by Nevin of a syringe within the issue of the interference.” Priority was therefore awarded to Nevin, the senior party. The Board of Appeals came to the same conclusion and affirmed the decision of the Examiner of Interferences.

Practically the only question upon this record is whether the appellant reduced his invention to practice in the latter part of 1921 and early part of 1922. In order to properly determine this matter, some view of the evidence must be had.

The parties in this interference are men of ability and high standing in their professions. The party Smith resides at Los Angeles, is a specialist in plastic oral surgery, and teaches, writes, and lectures extensively upon local anaesthesia and other subjects pertaining to his profession. He is a graduate of many educational institutions, and has lectured extensively throughout the United States and in Canada and Europe. For many years he attempted to develop instruments for use in his profession, and particularly hypodermic syringes and ampoules. The latter part of 1921 he developed and constructed a form of hypodermic syringe, which is thus described by him:

“The ampule was composed of glass, constricted at one end, I would call it the front end, into a taper; the other end, or rear end, was cut off; in other words not restricted. The tapered end contained a rubber band which was used as a gasket or washer. This rubber band or washer was approximately one-eighth of an inch in width and one or one and a half millimeters in thickness. It was located about one-half centimeter from the constricted glass tip. The rear end of *942 the ampule was closed by a rubber cork. The outer portion of this cork was located about two or three millimeters from the rear end. The cork contained a depression which was cylindrical. This depression extended almost through the cork. The ampule contained a liquid. The syringe was composed of metal— * ÜC «

“The glass tip is broken off; the ampule is inserted into the rear end of the syringe; it is forced forward into the front end of the syringe, into a conical shaped depression; the conical shaped depression being located in the front end of the syringe; the taper or conical-shaped depression is practically the same as the taper on the front end of the ampule which eontains*the rubber band or washer. The rear end of the syringe is composed of a solid member, in which the plunger rod moves freely; the rear end, containing the plunger rod, is placed over the rear end of the ampule and is locked in position by a bayonet shaped construction; the loeldng of the rear member in the syringe forces the ampule forward, causing a compression of the rubber washer or band located around the tapered front end in the conical shaped depression on the front end of the syringe. This locks the ampule in position and compresses the rubber washer in the front end, to prevent leakage.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
73 F.2d 940, 22 C.C.P.A. 748, 1934 CCPA LEXIS 266, Counsel Stack Legal Research, https://law.counselstack.com/opinion/smith-v-nevin-ccpa-1934.